Best wishes to Matt Wolf on his next adventure!
Matt joined the Elisseeff lab in 2014, bringing expertise in extracellular matrix (ECM) biomaterials for tissue engineering. He discovered that the same pro-regenerative environment generated by ECM biomaterials to encourage tissue healing also enabled the immune system to kill cancer cells. Cancer killing by immune…Read More
Postdoctoral Fellow Jim Andorko Accepts Next Position
We are happy to announce that Jim Andorko, PhD, an NIH T32 Postdoctoral Fellow in the lab, has recently secured his next position as a Senior Scientist at Interius Biotherapeutics, a new biotech company out of the University of Pennsylvania. In his next role, Jim…Read More
Liam Chung publishes a paper in Science Translational Medicine: IL17 and senescent cells play a role in foreign body response
Liam Chung, a postdoctoral fellow in the Elisseeff Lab, has recently published a paper in Science Translational Medicine. The article, linked below, discusses an immune-mediated response to materials implanted in the body, which can result in a fibrotic capsule around the implant. The role of interleukin…Read More
PRESS RELEASE – TEDCO Announces New Board Director, Jennifer Elisseeff
TEDCO Announces New Board Director Johns Hopkins’ Jennifer Elisseeff COLUMBIA, Md. (April 13, 2017) – The Maryland Technology Development Corporation (TEDCO) announced today that Governor Larry Hogan appointed Dr. Jennifer Elisseeff of Johns Hopkins University (JHU) to the Board of Directors. Dr. Elisseeff is the…Read More